This article is more than 1 year old.

COVID-19: Wockhardt in discussions with vaccine developers to offer drug substance

Mini

According to the company, the UK government has reserved one fill and finish production line at Wockhardt UK for its exclusive use for 18 months in order to guarantee the supply of vaccines required to fight against COVID-19.

COVID-19: Wockhardt in discussions with vaccine developers to offer drug substance
Drug firm Wockhardt on Tuesday said it is in discussions with a number of global COVID-19 vaccine developers to offer drug substance as well as fill and finish manufacturing facilities to them.
According to the company, the UK government has reserved one fill and finish production line at Wockhardt UK for its exclusive use for 18 months in order to guarantee the supply of vaccines required to fight against COVID-19.
”We are in discussions with a number of vaccine developers worldwide offering both drug substance, and fill and finish manufacturing, becausemost of the companies want drug substance, as well as formulation product,” Wockhardt Chairman Habil Khorakiwala, said during a virtual media conference.
Also Read
Wockhardt is offering such options as a contract manufacturing organisation activity or as distribution rights, depending on what they want, he added.
next story

Market Movers

Currency

CompanyPriceChng%Chng